Banded versus non-banded sleeve gastrectomy in obese patients: A systematic review & meta-analysis
- PMID: 35623944
- DOI: 10.1016/j.amjsurg.2022.05.015
Banded versus non-banded sleeve gastrectomy in obese patients: A systematic review & meta-analysis
Abstract
Background & aims: Weight regain represents an important issue after sleeve gastrectomy (SG), hence banded sleeve gastrectomy (BSG) was proposed. Aim of this meta-analysis was to compare the performance ofBSG versus SG in obese patients.
Methods: We searched the PubMed/Medline and Embase database through October 2020 and identified 6 studies, of which 2 randomized-controlled trials (recruiting673 patients). The primary outcome was % excess weight loss (%EWL); secondary outcomes included % total weight loss (%TWL), HbA1c improvement, overall complication and major complication rate, gastro-esophageal reflux disease (GERD)occurrence. We performed pairwise meta-analysis through a random effects model and expressed data as standardized mean difference (SMD) or odds ratio (OR) and 95% confidence interval (CI).
Results: A sharp decline in %EWL at 1 year was observed with both treatments with no significant difference (SMD 5.99, -1.17 to 13.16), whereas a clear benefit with BSG over SG was observed over time (SMD 15.95, 13.31 to 18.58 at 2 years; 18.37, 13.31 to 23.42 at 3 years; 24.75, 22.38 to 27.12 at 4 years; 29.85, 27.22 to 32.49 at 5 years). Meta-regression did not find any significant correlations between age, sex, and baseline BMI with %EWL. Similarly, no difference in terms of %TWL was observed at 1 year (SMD 1, -3.31 to 5.30), whereas the magnitude of the benefit with BSG increased significantly from the second year onwards (SMD 5.99, 3.7 to 8.27 at 2 year, 6.86, 5.13 to 8.59 at 3 year, and 9.36, 7.07 to 11.65 at 5 year). No difference in terms of HbA1c improvement was observed (SMD 0.40, -0.64 to 1.43). No difference in overall complication (OR 1.44, 0.55-3.76), major complications (OR 1.14, 0.52-1.87), and incidence of GERD was observed (OR 1.06, 0.56-2).
Conclusion: BSG is superior to SG in obese patients, due to its ability to significantly increase %EWL with no additional safety issues.
Keywords: BMI; Bariatric surgery; Diabetes; Reflux; Weight loss.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest We would like to state that this manuscript is not being considered for publication elsewhere and the authors have no conflicts of interests to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
